Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

Sector archive

Published briefings for one sector.

Browse recent results from companies in the same sector.

All briefingsConsumerHealthcareTransport & InfrastructurePrimary IndustriesPropertyInvestment CompaniesTechnologyConstruction & Materials
Open archive
Clear filters

Showing 1-24 of 81 published briefings.

Third Age Health Services (TAH)•FY26•Released 29 May 2026

PBT up 25.7% on ARC scale, full-year dividend reset to 8.0c

Aged-care consolidation lifted earnings and revenue mix, but a halved dividend and weaker cash conversion signal a clear reinvestment pivot.

Published 29 May 2026

Read briefing→
Truscreen Group (TRU)•FY26•Released 29 May 2026

Revenue up 42% but missed $2.8m guidance as debtors swelled to $1.0m

A 140bps gross margin lift is real, but a $1.0m receivables build and ongoing $2.5m operating cash burn keep the runway question open.

Published 29 May 2026

Read briefing→
Green Cross Health (GXH)•FY26•Released 29 May 2026

Medical services-led NPAT growth of 27.5% on 4.2% revenue lift

The earnings step-up was concentrated in the smaller Medical services segment while operating cash flow grew only 3.7% and free cash flow fell.

Published 29 May 2026

Read briefing→
Arvida Group (ARV)•FY26•Released 28 May 2026

Operating cash flow fell 33% as OCF/EBITDA dropped to 81% on lower ORA receipts

Underlying EBITDA rose 10% to $133m but operating cash inflows dropped $53m year-on-year, creating a material gap between reported earnings

Published 3 June 2026

Read briefing→
Promisia Healthcare (PHL)•FY26•Released 28 May 2026

FY26 NPAT $12.9m hinges on H2 swing; EBITDAF $6.6m the cleaner read

Full-year Cromwell consolidation and a sharp H2 earnings swing lift reported NPAT while net debt/EBITDAF falls from 11.1x to 5.8x.

Published 28 May 2026

Read briefing→
Ryman Healthcare (RYM)•FY26•Released 26 May 2026

Free cash flow swings to +NZ$188m as EBITDAF nearly doubles

Operating momentum is real but Ryman remains loss-making at the PBT line, and the FCF swing is partly capex-driven rather than purely earnings-led.

Published 26 May 2026

Read briefing→
Fisher & Paykel Healthcare (FPH)•FY26•Released 26 May 2026

FPH capex nearly doubled to NZ$195.2m, compressing FCF conversion

Operating cash flow rose to NZ$663.2m and cash built to NZ$461.1m, but capex hit 8.5% of revenue and FCF/NPAT fell to 95.3%.

Published 26 May 2026

Read briefing→
BLIS Technologies (BLT)•FY26•Released 21 May 2026

Revenue up 16% but working-capital absorption turned operating cash flow

A NZ$1.8m working-capital build—versus a historical average release of NZ$0.2m—consumed all reported profit and then some, turning free cash flow

Published 21 May 2026

Read briefing→
Radius Residential Care (RAD)•FY26•Released 13 May 2026

PBT up 36.2% and cash conversion at 91.8% as capex more than doubled

Underlying earnings ran above the historical baseline, but H2 NPAT roughly halved versus H1 as growth-strategy capex stepped up to NZ$16.1m.

Published 19 May 2026

Read briefing→
Rua Bioscience (RUA)•HY26•Released 27 February 2026

Revenue grew to NZ$1.3m but losses persisted as borrowings quadrupled

A 4.5x step-up in debt funded most of the cash uplift while total assets sit below the supplied historical range.

Published 22 May 2026

Read briefing→
Summerset Group Holdings (SUM)•FY25•Released 27 February 2026

PBT fell 32.2% on smaller revaluation gains; underlying profit up 13%

IFRS earnings dropped on lower investment property fair-value uplifts, masking a 26% jump in unit settlements and 23.7% rise in operating cash flow.

Published 21 April 2026

Read briefing→
EBOS Group (EBO)•HY26•Released 25 February 2026

Cash conversion collapsed to 15.4% as working capital absorbed $348m

Revenue grew 13.0% and FY26 EBITDA guidance was reaffirmed, but operating cash flow fell to $46.6m and the dividend was not covered by free cash flow.

Published 21 April 2026

Read briefing→
Green Cross Health (GXH)•HY26•Released 28 November 2025

NPAT grew 28.6% but pre-lease FCF fell to NZ$15.6m, a 3-year low

Working capital absorption and a near-tripling of capex weakened cash conversion even as reported earnings grew above the historical range.

Published 22 April 2026

Read briefing→
Arvida Group (ARV)•HY26•Released 28 November 2025

Operating cash flow fell 44% as gross borrowings climbed to $1.0bn

Operating EBITDA was nearly flat but operating cash flow fell 44% and gross borrowings rose 34% to $1.0bn against a subdued property market.

Published 21 April 2026

Read briefing→
BLIS Technologies (BLT)•HY26•Released 27 November 2025

Revenue grew 28.1% but operating cash swung negative on inventory build

A $1.4m working-capital absorption pushed HY26 operating cash flow to -$0.5m, contradicting the $0.5m EBITDA and PBT-doubling headline.

Published 22 April 2026

Read briefing→
Ryman Healthcare (RYM)•HY26•Released 27 November 2025

PBT collapsed 123% to a NZ$40.2m loss as debt fell NZ$928m

Maiden NZ$56.2m FCF and the balance sheet reset frame the upside, but a NZ$152.7m receivables release flatters the cash result.

Published 21 April 2026

Read briefing→
Fisher & Paykel Healthcare (FPH)•HY26•Released 26 November 2025

FPH PBT margin reached 26.1%, lifting profit 37.5% on 14.4% revenue growth

Operating leverage pushed margins above the recent historical range even as FCF conversion eased from 110.6% to 81.3% of NPAT.

Published 21 April 2026

Read briefing→
Pacific Edge (PEB)•HY26•Released 25 November 2025

Revenue down 45.8% as Medicare coverage loss halves US diagnostic income

Pacific Edge's HY26 operating loss widened to NZ$19.1M after Medicare coverage was withdrawn, with just NZ$15.1M cash remaining to fund an ongoing

Published 18 May 2026

Read briefing→
Oceania Healthcare (OCA)•HY26•Released 21 November 2025

OCA swung to PBT positive but capex jumped 82% to 40.4% of revenue

EBITDA rose 7.4% on flat revenue and PBT turned positive at $1.0m, but a doubled investment cycle kept free cash flow at -$8.4m.

Published 21 April 2026

Read briefing→
Radius Residential Care (RAD)•HY26•Released 19 November 2025

PBT up 204% on 19% revenue growth as cash conversion lifted to 89%

A lower effective tax rate flattered NPAT, but EBITDA +41% and leverage cut to 4.3x point to genuine operating gains.

Published 23 April 2026

Read briefing→
Rua Bioscience (RUA)•FY25•Released 1 September 2025

RUA revenue rose 490.6% but the business remains deeply cash-negative

Strong commercial momentum cut the loss before tax by 74.8%, yet cash fell to NZD 0.2m and operating outflows persist, making runway the central

Published 19 May 2026

Read briefing→
Summerset Group Holdings (SUM)•HY25•Released 28 August 2025

Underlying profit +19% on 692 sales, but NPAT flattered by tax swing

OCF rose 19.3% to $228.7m and gross borrowings grew 21.3% to $1.87b as $311.6m of development capex left free cash flow at -$17.7m.

Published 23 April 2026

Read briefing→
EBOS Group (EBO)•FY25•Released 27 August 2025

Reported PBT fell 21.1% while cash conversion rose to 75.3%

Reported revenue and earnings fell sharply against a non-comparable prior period, but cash generation and leverage strengthened materially.

Published 22 April 2026

Read briefing→
Pacific Edge (PEB)•FY25•Released 30 May 2025

Cash falls 67.6% to NZ$9.5M as revenue drops 8.6% on Medicare uncertainty

Pacific Edge burned NZ$24.7M in operating cash in FY25, leaving a closing balance of NZ$9.5M that raises immediate questions about runway without a

Published 22 May 2026

Read briefing→
1
2
3
4
Next page→

Get reporting-season briefings

Get full NZX result briefings by email as new coverage is published.